Meeting Themes

Meeting Themes

Digital Health • Sexual Health • Treatment Toxicities • Cancer Survivorship


Digital Health. The meeting’s proximity to Silicon Valley’s technological expertise inspired this focus on the intersection of digital technology and supportive care, from devices and artificial intelligence to teleoncology. A plenary session titled “Digital Health: Science Fact, Not Science Fiction” will address applications of digital health technology in the field of oncology. The session will also feature overviews of artificial intelligence, virtual reality, augmented reality, and wearable devices that can help meet the challenges of people with cancer. A parallel session, “Digital Health in Action,” will include presentations on teleoncology and the ways in which technology can be applied in symptom assessment of cancer patients.


Treatment Toxicities. Advances in pharmacological and cellular treatments, as well as radiotherapy, have resulted in dramatic benefits for cancer patients, but also in new toxicities. The Annual Meeting will include three sessions devoted to understanding the basic mechanisms and the variety of complications arising from new cancer treatments. A plenary session, “New Treatments, New Toxicities,” will include presentations on patient-reported outcomes, CAR T-cell therapy toxicity, and new radiotherapy modalities. A parallel session (“Complications of Immunotherapy I”) as well as a workshop (“Complications of Immunotherapy II) will explore basic mechanisms, immune-related adverse events, and emergencies. These sessions will include some presentations on specific toxicities: rheumatological, renal, skin, and colitis. The workshop will also feature a discussion of effective patient-provider communication about toxicities.

Sexual Health. This topic will be addressed in several sessions over the course of the meeting. A plenary session on “Sexual Health Treatment Strategies” will include presentations on sexual problems in both men and women, as well as a presentation on oncofertility. The meeting will also feature three parallel sessions devoted to topics in sexual health. The first, “Sexual Health in Head and Neck Cancer,” will address sexuality in the era of HPV, featuring common patient questions and answers. Other topics in the same session include body image and sexuality research, interventions and management strategies for sexual dysfunction, as well as suicide rates and risk factors — all with respect to head and neck cancer patients and survivors. A second parallel session, “Let’s Talk About Sex,” will focus on sexual and reproductive health, as well as sexual dysfunction of adolescent and young adult cancer patients, and sexual health and preparedness in survivors of childhood cancer making the child-to-adult transition. A third parallel session, “Sexual Health: A Multidisciplinary Problem,” will address the complex nature of sexual health and problems among cancer patients and their partners.

Survivorship. The subject of cancer survivorship will be addressed in several sessions over the course of the meeting. A workshop, “Technological Advances and Emerging Strategies for Treatment-Related Symptoms During Survivorship,” will include such topics as enhancing self-management through the use of mobile health technology, technologies for optimizing symptom management and toxicity assessment, and discussions of future research and partnerships. A parallel session, “Cancer Survivorship across the Life Cycle,” will consider cancer survivorship among children, adolescents, adults, and the elderly. “Cancer Survivorship among Adolescents and Young Adults” is the title of a joint session of MASCC and JASCC, the Japanese Association of Supportive Care in Cancer. Speakers will provide an overview of the issues, data on the follow-up of adolescent and young adult survivors, and ongoing trials in Asia. Another parallel session will feature a debate titled “Every Cancer Survivor Must Have a Written Survivorship Care Plan,” featuring speakers from Australia, Mexico, the United Kingdom, and the United States.


Plenary Session 1: Digital Health: Science Fact, Not Science Fiction – Friday, June 21

Chair: Ian Olver (Australia)

Roni Zeiger (USA): Digital Health and Oncology: Towards Connected Cancer Care
Alice Landis-McGrath (USA): Overview of Artificial Intelligence (AI)
David Rhew (USA): Overview of Virtual Reality, Augmented Reality, and Wearables Digital Health

Parallel Session: Digital Health in Action – Friday, June 21
Chair: Declan Walsh (USA)

Ian Olver (Australia): Teleoncology
Christine Miaskowski (USA): Symptom Assessment of Cancer Patients

Plenary Session 2: New Treatments, New Toxicities - Saturday, June 22
Chair: Rajesh Lalla (USA)

Ethan Basch (USA): Patient-Reported Outcomes (PRO-CTCAE)
Crystal Mackall (USA): CAR T-Cell Therapy Toxicity

Sue Yom (USA): New Radiotherapy Modalities

Parallel Session: Complications of Immunotherapy, I - Saturday, June 22
Chairs: Bernardo Rapoport (South Africa) and Mario Lacouture (USA)

Bernardo Rapoport (South Africa): Basic Mechanisms
Michael Postow (USA): Overview of Recommendations on Immune-Related Adverse Events
Tim Cooksley (UK): Emergencies
Anne Bass (USA): Rheumatological Toxicities
Jean Klastersky (Belgium): Renal Toxicities

Workshop: Complications of Immunotherapy, II - Saturday, June 22
Chairs: Bernardo Rapoport (South Africa) and Mario Lacouture (USA)

Michael Postow (USA): Pulmonary, Rare, and Multiple Toxicities
Mario Lacouture (USA): Skin Toxicities
Pamela Ginex (USA): Effective Patient-Healthcare Provider Communication
Michael Postow (USA): Case 1: Multiple Immune-Related Adverse Events
Michael Dougan (USA): Case 2: Colitis Refractory to Infliximab

Plenary Session 3: Sexual Health: Treatment Strategies – Friday, June 21
Chair: Hope Rugo (USA)

John Mulhall (USA): Sexual Problems in Male Cancer Patients
Tami Rowen (USA): Sexual Problems in Female Cancer Patients
Francesca Duncan (USA): Oncofertility

Parallel Session: Sexual Health in Head and Neck Cancer – Friday, June 21
Chairs: Deborah Saunders (Canada) and Cherry Estilo (USA)

Eleni Rettig (USA): Head and Neck Cancer and Sexuality in the Era of HPV: Common Patient Questions and Answers
Bethany Rhoten (USA): Body Image and Sexuality Research in Head and Neck Cancer
Kari Torbicki (Canada): Approaches to Interventions and Management Strategies for Sexual Dysfunction in Head and Neck Cancer
Nosayaba Osazuma-Peters (USA): Understanding Suicide Rate, Risk Factors, and Trends Among Head and Neck Cancer Survivors

Parallel Session: Let’s Talk About Sex – Friday, June 21
Chairs: Andrea Orsey (USA) and Jason Freedman (USA)

Natasha Frederick (USA): Sexual and Reproductive Health of Adolescent and Young Adult Patients
Faith Gibson (UK): Sexual Health and Preparedness in Survivors of Childhood Cancer: The Child-to-Adult Transition
Leslie Schover (USA): Sexual Dysfunction in Adolescent and Young Adult Patients and Survivors

Parallel Session: Sexual Health: A Multidisciplinary Problem – Sunday, June 23
Chair: Penelope Schofield (Australia)

Debra Barton (USA): Sexual Problems in Cancer Patients: An Introduction
Shari Goldfarb (USA): Overcoming the Barriers
Jane Ussher (Australia): Sexual Issues in Partners of Cancer Patients

JASCC/MASCC Joint Session: Cancer Survivorship in Adolescents and Young Adults – Saturday, June 22

Chairs: Mitsue Saito (Japan) and Margaret Fitch (Canada)

Michael Feuerstein (USA): Overview of the Issues
Miyako Takahashi (Japan): Getting Back to "Normal”
Margaret Fitch (Canada): Follow-up of AYA Cancer Survivors
Alexandre Chan (Singapore): Ongoing Trials – AYA Cancer Survivors in Asia

Parallel Session: Cancer Survivorship Across the Life Cycle – Saturday, June 22
Chairs: Lidia Schapira (USA) and Bogda Koczwara (Australia)

Faith Gibson (UK): Pediatric and AYA Cancer Survivors
Michael Jefford (Australia): Adult Cancer Survivors
William Dale (USA): Geriatric Cancer Survivors

Debate: Every Cancer Survivor Must Have a Written Survivorship Care Plan – Saturday, June 22
Facilitator: Lidia Schapira (USA)

Debaters: William Dale (USA), Faith Gibson (UK), Michael Jefford (Australia), Bogda Koczwara (Australia), Deborah Mayer (USA), and Enrique Soto-Perez de Celis (Mexico)

Workshop: Technological Advances and Emerging Strategies for Treatment-Related Symptoms During Cancer Survivorship  Sunday, June 23
Chair: Alexandre Chan (Singapore)

Doris Howell (Canada): Enhancing Self-Management Through the Use of Mobile Health
Maryam Lustberg (USA): Innovative Technologies to Optimize Symptom Management and Toxicity Assessment
Case Panel Discussion, Interactive Discussion, and a Strategic Plan Discussion on Future Research and Partnerships. Discussants: Karen Mustian (USA) and Raymond Chan (Australia)


Keep Me Updated